No abstract available
MeSH terms
-
Antineoplastic Agents / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Clinical Trials as Topic
-
Drug Evaluation
-
Humans
-
Immunotherapy / methods
-
Interleukin-2* / administration & dosage
-
Interleukin-2* / adverse effects
-
Interleukin-2* / therapeutic use
-
Killer Cells, Natural / immunology*
-
Melanoma / drug therapy
-
Melanoma / secondary
-
Melanoma / therapy*
Substances
-
Antineoplastic Agents
-
Interleukin-2